Virginia Commonwealth University Health System is a clinical research site located in Richmond, Virginia, United States 23298.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Virginia Commonwealth University Health System has participated in 51 clinical trials with 8 currently active.
Therapeutic areas: Liver Transplant, Paroxysmal Atrial Fibrillation, Amyloid Cardiomyopathy, Transthyretin-Related.
Sponsors: TransMedics, Boston Scientific Corporation, Eidos Therapeutics, a BridgeBio company.
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Virginia Commonwealth University Health System has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Commonwealth University Health System has 51 clinical trials on record, with 8 currently active. Their work covers Liver Transplant, Paroxysmal Atrial Fibrillation, Amyloid Cardiomyopathy, Transthyretin-Related.
Yes — Virginia Commonwealth University Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.